Subpopulations of Lymphocytes and Cytokine Status of Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

被引:0
作者
Kondratiuk, K. O. [1 ]
Kobyliak, N. M. [1 ]
Gurianov, V. G. [1 ]
Lisyany, N., I [2 ]
Mykhalchyshyn, G. P. [1 ]
Bodnar, P. M. [1 ]
机构
[1] Bogomolest Natl Med Univ, T Shevchenko Blvd,13, UA-01601 Kiev, Ukraine
[2] NAMS Ukraine, AP Romodanov Inst Neurosurg, Kiev, Ukraine
来源
RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES | 2015年 / 6卷 / 02期
关键词
non-alcoholic fatty liver disease; type; 2; diabetes; cytokines; lymphocytes;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have observed 118 patients, including 64 patients with T2DM and NAFLD (I group), 26 patients with T2DM (II group) and 28 patients with NAFLD (III group). The control group consisted of 25 apparently healthy individuals. We have determined the quantitative content of lymphocyte subpopulations in peripheral blood, the concentration of cytokines (interleukin (IL) 1 beta, 2, 4, 6, 8, 10, 17, TNF-alpha and IFN-gamma) in peripheral blood serum and in coprofiltrates, and evaluated the state of the microbiota of the intestine as a result of bacteriological examination of faeces. The studies have found that each of the studied pathologies (T2DM, NAFLD and their combination) is characterized by its own cytokine status, which reflects both the presence of inflammatory processes and focus immunopathological reactions in the body. Identified changes in the levels of cytokines and lymphocyte subpopulation content in combination T2DM with NAFLD can be used both for diagnosis and for predicting adverse development of this disease, the intensity of the proliferation of connective tissue and the degree of fibrosis formation.
引用
收藏
页码:1387 / 1394
页数:8
相关论文
共 19 条
  • [1] [Anonymous], 2013, IDF DIABETES ATLAS, P155
  • [2] Belyakova NA, 2011, QUESTIONS PATHOGENES, V2, P9
  • [3] Bodnar P., 2012, ENDOCRINOLOGY, V17, P94
  • [4] Diehl AM, 2002, AM J PHYSIOL-GASTR L, V282, P105
  • [5] HvorostInka VM, 2009, MODERN GASTROENTEROL, V3, P91
  • [6] KETLINSKY SA, 1995, IMMUNOLOGIYA, V3, P30
  • [7] Klyaritska IL, 2010, ARCH CLIN EXP MED, V19, P167
  • [8] Korniychuk IYu, 2011, BUKOVYNSKIY MED B, V15, P214
  • [9] Natural killer T cells and non-alcoholic fatty liver disease: Fat chews on the immune system
    Kremer, Michael
    Hines, Ian N.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (03) : 487 - 488
  • [10] Mammaev SN, 2007, RUSSIAN J GASTROENTE, V4, P35